Concepedia

Publication | Open Access

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors

DOIFull Paper Access

170

Citations

12

References

2020

Year

Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Bárbara Hermes, J. Schütte, Silke Cameron, Peter Hohenberger, Philipp J. Jost, Salah‐Eddin Al‐Batran,
JAMA Oncology

Abstract

ClinicalTrials.gov Identifier: NCT00116935.

References

YearCitations

Page 1